Latest News & Updates

Breaking News

  • 16 hours ago

  • Team Pharma Now

Pharma Now Launches India's Biggest Pharma IT Summit - Pharma AI & Data Congress on 3rd June 2026
Breaking News
Partner Therapeutics Gains FDA Approval for Zenocutuzumab-zbco in NRG1-Fusion Cholangiocarcinoma Five Months Early

Pharma Now Editorial Team

Other trending news you may like to read

Pharma Now Launches India's Biggest Pharma IT Summit - Pharma AI & Data Congress on 3rd June 2026

Pharma AI & Data Congress 2026 launches June 3 in Mumbai for 130+ pharma IT leaders to tackle AI deployment under GAMP AI, EU AI Act, and DPDPA compliance.

Team Pharma Now

Pharma Now

Partner Therapeutics Gains FDA Approval for Zenocutuzumab-zbco in NRG1-Fusion Cholangiocarcinoma Five Months Early

FDA approved zenocutuzumab-zbco for NRG1-fusion cholangiocarcinoma five months ahead of goal date under the CNPV pilot program.

Pharma Now Editorial Team

Pharma Now

Moleculin Biotech Secures Hong Kong Patent for Liposomal Annamycin Ahead of Phase 3 Data

Moleculin Biotech adds Hong Kong to its Annamycin IP portfolio ahead of imminent Phase 3 data, extending formulation exclusivity through 2040.

Pharma Now Editorial Team

Pharma Now

FDA Issues Final Guidance on Postapproval Pregnancy Safety Studies for Drugs and Biologics

FDA's final guidance on postapproval pregnancy safety studies sets a methodological framework covering registries, real-world data, and case-based descriptive studies.

Pharma Now Editorial Team

Pharma Now